nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—KCNH2—Sunitinib—pancreatic cancer	0.0758	0.137	CbGbCtD
Dronedarone—ALB—Erlotinib—pancreatic cancer	0.0549	0.0991	CbGbCtD
Dronedarone—ALB—Irinotecan—pancreatic cancer	0.0496	0.0895	CbGbCtD
Dronedarone—ALB—Fluorouracil—pancreatic cancer	0.0476	0.0859	CbGbCtD
Dronedarone—ABCB1—Tamoxifen—pancreatic cancer	0.0338	0.061	CbGbCtD
Dronedarone—CYP2D6—Tamoxifen—pancreatic cancer	0.0318	0.0575	CbGbCtD
Dronedarone—ABCB1—Gemcitabine—pancreatic cancer	0.0291	0.0525	CbGbCtD
Dronedarone—ABCB1—Erlotinib—pancreatic cancer	0.0287	0.0518	CbGbCtD
Dronedarone—CYP2D6—Erlotinib—pancreatic cancer	0.0271	0.0489	CbGbCtD
Dronedarone—ABCB1—Irinotecan—pancreatic cancer	0.0259	0.0468	CbGbCtD
Dronedarone—CYP3A4—Tamoxifen—pancreatic cancer	0.0202	0.0365	CbGbCtD
Dronedarone—ABCB1—Docetaxel—pancreatic cancer	0.019	0.0343	CbGbCtD
Dronedarone—ABCB1—Sunitinib—pancreatic cancer	0.0189	0.0342	CbGbCtD
Dronedarone—CYP3A4—Erlotinib—pancreatic cancer	0.0172	0.0311	CbGbCtD
Dronedarone—CYP3A4—Irinotecan—pancreatic cancer	0.0155	0.0281	CbGbCtD
Dronedarone—ABCB1—Doxorubicin—pancreatic cancer	0.0142	0.0256	CbGbCtD
Dronedarone—CYP2D6—Doxorubicin—pancreatic cancer	0.0134	0.0241	CbGbCtD
Dronedarone—Pulmonary toxicity—Erlotinib—pancreatic cancer	0.0129	0.0516	CcSEcCtD
Dronedarone—CYP3A4—Docetaxel—pancreatic cancer	0.0114	0.0206	CbGbCtD
Dronedarone—CYP3A4—Sunitinib—pancreatic cancer	0.0113	0.0205	CbGbCtD
Dronedarone—Pulmonary toxicity—Gemcitabine—pancreatic cancer	0.00899	0.0358	CcSEcCtD
Dronedarone—CYP3A4—Doxorubicin—pancreatic cancer	0.00849	0.0153	CbGbCtD
Dronedarone—Pulmonary fibrosis—Erlotinib—pancreatic cancer	0.00668	0.0266	CcSEcCtD
Dronedarone—Pulmonary fibrosis—Gemcitabine—pancreatic cancer	0.00464	0.0185	CcSEcCtD
Dronedarone—Interstitial lung disease—Tamoxifen—pancreatic cancer	0.0042	0.0167	CcSEcCtD
Dronedarone—Interstitial lung disease—Erlotinib—pancreatic cancer	0.00415	0.0165	CcSEcCtD
Dronedarone—Atrial flutter—Docetaxel—pancreatic cancer	0.00381	0.0152	CcSEcCtD
Dronedarone—Liver injury—Tamoxifen—pancreatic cancer	0.00353	0.0141	CcSEcCtD
Dronedarone—Rash erythematous—Sunitinib—pancreatic cancer	0.00332	0.0132	CcSEcCtD
Dronedarone—Hypomagnesaemia—Irinotecan—pancreatic cancer	0.0033	0.0131	CcSEcCtD
Dronedarone—Pulmonary fibrosis—Docetaxel—pancreatic cancer	0.00329	0.0131	CcSEcCtD
Dronedarone—Hypomagnesaemia—Gemcitabine—pancreatic cancer	0.00321	0.0128	CcSEcCtD
Dronedarone—Ageusia—Sunitinib—pancreatic cancer	0.00314	0.0125	CcSEcCtD
Dronedarone—Vasculitis—Tamoxifen—pancreatic cancer	0.00304	0.0121	CcSEcCtD
Dronedarone—Interstitial lung disease—Gemcitabine—pancreatic cancer	0.00288	0.0115	CcSEcCtD
Dronedarone—Dermatitis atopic—Gemcitabine—pancreatic cancer	0.00276	0.011	CcSEcCtD
Dronedarone—Vasculitis—Gemcitabine—pancreatic cancer	0.00209	0.00833	CcSEcCtD
Dronedarone—Eczema—Sunitinib—pancreatic cancer	0.00206	0.00819	CcSEcCtD
Dronedarone—Interstitial lung disease—Docetaxel—pancreatic cancer	0.00205	0.00816	CcSEcCtD
Dronedarone—Cardiac failure congestive—Sunitinib—pancreatic cancer	0.00204	0.00811	CcSEcCtD
Dronedarone—Blood creatinine increased—Tamoxifen—pancreatic cancer	0.00202	0.00805	CcSEcCtD
Dronedarone—Dermatitis atopic—Docetaxel—pancreatic cancer	0.00196	0.0078	CcSEcCtD
Dronedarone—Hypokalaemia—Erlotinib—pancreatic cancer	0.00194	0.00774	CcSEcCtD
Dronedarone—Cardiac failure—Sunitinib—pancreatic cancer	0.00189	0.00754	CcSEcCtD
Dronedarone—Rash erythematous—Docetaxel—pancreatic cancer	0.00189	0.00754	CcSEcCtD
Dronedarone—Ageusia—Docetaxel—pancreatic cancer	0.00179	0.00713	CcSEcCtD
Dronedarone—Blood creatinine increased—Sunitinib—pancreatic cancer	0.00173	0.00689	CcSEcCtD
Dronedarone—Hypokalaemia—Sunitinib—pancreatic cancer	0.00168	0.0067	CcSEcCtD
Dronedarone—Pneumonia—Tamoxifen—pancreatic cancer	0.00167	0.00666	CcSEcCtD
Dronedarone—Pneumonia—Erlotinib—pancreatic cancer	0.00165	0.00659	CcSEcCtD
Dronedarone—Cardiac failure congestive—Gemcitabine—pancreatic cancer	0.00163	0.00651	CcSEcCtD
Dronedarone—Hepatobiliary disease—Erlotinib—pancreatic cancer	0.00156	0.0062	CcSEcCtD
Dronedarone—Hypomagnesaemia—Epirubicin—pancreatic cancer	0.00154	0.00613	CcSEcCtD
Dronedarone—Cardiac failure—Gemcitabine—pancreatic cancer	0.00152	0.00605	CcSEcCtD
Dronedarone—Cardiac failure—Fluorouracil—pancreatic cancer	0.00149	0.00595	CcSEcCtD
Dronedarone—Pneumonia—Sunitinib—pancreatic cancer	0.00143	0.0057	CcSEcCtD
Dronedarone—Blood creatinine increased—Irinotecan—pancreatic cancer	0.00143	0.00568	CcSEcCtD
Dronedarone—Hypomagnesaemia—Doxorubicin—pancreatic cancer	0.00142	0.00567	CcSEcCtD
Dronedarone—Blood creatinine increased—Gemcitabine—pancreatic cancer	0.00139	0.00553	CcSEcCtD
Dronedarone—Hypokalaemia—Irinotecan—pancreatic cancer	0.00138	0.00552	CcSEcCtD
Dronedarone—Hypokalaemia—Gemcitabine—pancreatic cancer	0.00135	0.00537	CcSEcCtD
Dronedarone—Hepatobiliary disease—Sunitinib—pancreatic cancer	0.00135	0.00536	CcSEcCtD
Dronedarone—Mediastinal disorder—Erlotinib—pancreatic cancer	0.00133	0.0053	CcSEcCtD
Dronedarone—Dermatitis atopic—Epirubicin—pancreatic cancer	0.00132	0.00526	CcSEcCtD
Dronedarone—Bradycardia—Sunitinib—pancreatic cancer	0.0013	0.00518	CcSEcCtD
Dronedarone—Erythema—Tamoxifen—pancreatic cancer	0.0013	0.00517	CcSEcCtD
Dronedarone—Erythema—Erlotinib—pancreatic cancer	0.00129	0.00512	CcSEcCtD
Dronedarone—Rash erythematous—Epirubicin—pancreatic cancer	0.00128	0.00508	CcSEcCtD
Dronedarone—Dysgeusia—Tamoxifen—pancreatic cancer	0.00127	0.00507	CcSEcCtD
Dronedarone—Dermatitis atopic—Doxorubicin—pancreatic cancer	0.00122	0.00487	CcSEcCtD
Dronedarone—Ageusia—Epirubicin—pancreatic cancer	0.00121	0.00481	CcSEcCtD
Dronedarone—Angioedema—Tamoxifen—pancreatic cancer	0.00119	0.00473	CcSEcCtD
Dronedarone—Cardiac disorder—Sunitinib—pancreatic cancer	0.00119	0.00472	CcSEcCtD
Dronedarone—Rash erythematous—Doxorubicin—pancreatic cancer	0.00118	0.0047	CcSEcCtD
Dronedarone—Pneumonia—Irinotecan—pancreatic cancer	0.00118	0.0047	CcSEcCtD
Dronedarone—Liver injury—Epirubicin—pancreatic cancer	0.00116	0.00463	CcSEcCtD
Dronedarone—Cardiac failure congestive—Docetaxel—pancreatic cancer	0.00116	0.00462	CcSEcCtD
Dronedarone—Angiopathy—Sunitinib—pancreatic cancer	0.00116	0.00462	CcSEcCtD
Dronedarone—Immune system disorder—Sunitinib—pancreatic cancer	0.00115	0.0046	CcSEcCtD
Dronedarone—Mediastinal disorder—Sunitinib—pancreatic cancer	0.00115	0.00459	CcSEcCtD
Dronedarone—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.00115	0.00458	CcSEcCtD
Dronedarone—Pneumonia—Gemcitabine—pancreatic cancer	0.00115	0.00458	CcSEcCtD
Dronedarone—Pneumonia—Fluorouracil—pancreatic cancer	0.00113	0.0045	CcSEcCtD
Dronedarone—Ageusia—Doxorubicin—pancreatic cancer	0.00112	0.00445	CcSEcCtD
Dronedarone—Erythema—Sunitinib—pancreatic cancer	0.00111	0.00443	CcSEcCtD
Dronedarone—Dysgeusia—Sunitinib—pancreatic cancer	0.00109	0.00434	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00109	0.00433	CcSEcCtD
Dronedarone—Hepatobiliary disease—Gemcitabine—pancreatic cancer	0.00108	0.0043	CcSEcCtD
Dronedarone—Cardiac failure—Docetaxel—pancreatic cancer	0.00108	0.00429	CcSEcCtD
Dronedarone—Liver injury—Doxorubicin—pancreatic cancer	0.00107	0.00428	CcSEcCtD
Dronedarone—Bradycardia—Irinotecan—pancreatic cancer	0.00107	0.00427	CcSEcCtD
Dronedarone—Nervous system disorder—Erlotinib—pancreatic cancer	0.00103	0.0041	CcSEcCtD
Dronedarone—Skin disorder—Erlotinib—pancreatic cancer	0.00102	0.00406	CcSEcCtD
Dronedarone—Angioedema—Sunitinib—pancreatic cancer	0.00102	0.00405	CcSEcCtD
Dronedarone—Cardiac disorder—Irinotecan—pancreatic cancer	0.000977	0.00389	CcSEcCtD
Dronedarone—Angiopathy—Irinotecan—pancreatic cancer	0.000955	0.0038	CcSEcCtD
Dronedarone—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000952	0.00379	CcSEcCtD
Dronedarone—Immune system disorder—Irinotecan—pancreatic cancer	0.000951	0.00379	CcSEcCtD
Dronedarone—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000949	0.00378	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000941	0.00375	CcSEcCtD
Dronedarone—Dyspepsia—Tamoxifen—pancreatic cancer	0.000933	0.00372	CcSEcCtD
Dronedarone—Angiopathy—Gemcitabine—pancreatic cancer	0.00093	0.00371	CcSEcCtD
Dronedarone—Immune system disorder—Gemcitabine—pancreatic cancer	0.000926	0.00369	CcSEcCtD
Dronedarone—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.000924	0.00368	CcSEcCtD
Dronedarone—Dyspepsia—Erlotinib—pancreatic cancer	0.000923	0.00368	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000915	0.00365	CcSEcCtD
Dronedarone—Fatigue—Tamoxifen—pancreatic cancer	0.000914	0.00364	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000905	0.00361	CcSEcCtD
Dronedarone—Fatigue—Erlotinib—pancreatic cancer	0.000904	0.0036	CcSEcCtD
Dronedarone—Erythema—Gemcitabine—pancreatic cancer	0.000893	0.00356	CcSEcCtD
Dronedarone—Nervous system disorder—Sunitinib—pancreatic cancer	0.00089	0.00355	CcSEcCtD
Dronedarone—Skin disorder—Sunitinib—pancreatic cancer	0.000882	0.00351	CcSEcCtD
Dronedarone—Erythema—Fluorouracil—pancreatic cancer	0.000878	0.0035	CcSEcCtD
Dronedarone—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000867	0.00345	CcSEcCtD
Dronedarone—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000858	0.00342	CcSEcCtD
Dronedarone—Abdominal pain—Tamoxifen—pancreatic cancer	0.000838	0.00334	CcSEcCtD
Dronedarone—Abdominal pain—Erlotinib—pancreatic cancer	0.000829	0.0033	CcSEcCtD
Dronedarone—Pneumonia—Docetaxel—pancreatic cancer	0.000815	0.00325	CcSEcCtD
Dronedarone—Dyspepsia—Sunitinib—pancreatic cancer	0.000799	0.00318	CcSEcCtD
Dronedarone—Eczema—Epirubicin—pancreatic cancer	0.000789	0.00315	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000784	0.00312	CcSEcCtD
Dronedarone—Fatigue—Sunitinib—pancreatic cancer	0.000783	0.00312	CcSEcCtD
Dronedarone—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.000782	0.00312	CcSEcCtD
Dronedarone—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000767	0.00305	CcSEcCtD
Dronedarone—Asthenia—Tamoxifen—pancreatic cancer	0.000761	0.00303	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000755	0.00301	CcSEcCtD
Dronedarone—Asthenia—Erlotinib—pancreatic cancer	0.000752	0.003	CcSEcCtD
Dronedarone—Pruritus—Tamoxifen—pancreatic cancer	0.00075	0.00299	CcSEcCtD
Dronedarone—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000748	0.00298	CcSEcCtD
Dronedarone—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000742	0.00296	CcSEcCtD
Dronedarone—Pruritus—Erlotinib—pancreatic cancer	0.000742	0.00296	CcSEcCtD
Dronedarone—Nervous system disorder—Irinotecan—pancreatic cancer	0.000733	0.00292	CcSEcCtD
Dronedarone—Eczema—Doxorubicin—pancreatic cancer	0.00073	0.00291	CcSEcCtD
Dronedarone—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000728	0.0029	CcSEcCtD
Dronedarone—Cardiac failure—Epirubicin—pancreatic cancer	0.000727	0.0029	CcSEcCtD
Dronedarone—Diarrhoea—Tamoxifen—pancreatic cancer	0.000725	0.00289	CcSEcCtD
Dronedarone—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000724	0.00288	CcSEcCtD
Dronedarone—Abdominal pain—Sunitinib—pancreatic cancer	0.000718	0.00286	CcSEcCtD
Dronedarone—Diarrhoea—Erlotinib—pancreatic cancer	0.000718	0.00286	CcSEcCtD
Dronedarone—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000716	0.00285	CcSEcCtD
Dronedarone—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000714	0.00285	CcSEcCtD
Dronedarone—Skin disorder—Gemcitabine—pancreatic cancer	0.000708	0.00282	CcSEcCtD
Dronedarone—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000702	0.0028	CcSEcCtD
Dronedarone—Cardiac disorder—Docetaxel—pancreatic cancer	0.000675	0.00269	CcSEcCtD
Dronedarone—Vomiting—Tamoxifen—pancreatic cancer	0.000674	0.00269	CcSEcCtD
Dronedarone—Cardiac failure—Doxorubicin—pancreatic cancer	0.000673	0.00268	CcSEcCtD
Dronedarone—Rash—Tamoxifen—pancreatic cancer	0.000668	0.00266	CcSEcCtD
Dronedarone—Dermatitis—Tamoxifen—pancreatic cancer	0.000668	0.00266	CcSEcCtD
Dronedarone—Vomiting—Erlotinib—pancreatic cancer	0.000667	0.00266	CcSEcCtD
Dronedarone—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000665	0.00265	CcSEcCtD
Dronedarone—Rash—Erlotinib—pancreatic cancer	0.000661	0.00263	CcSEcCtD
Dronedarone—Dermatitis—Erlotinib—pancreatic cancer	0.000661	0.00263	CcSEcCtD
Dronedarone—Angiopathy—Docetaxel—pancreatic cancer	0.00066	0.00263	CcSEcCtD
Dronedarone—Dyspepsia—Irinotecan—pancreatic cancer	0.000658	0.00262	CcSEcCtD
Dronedarone—Immune system disorder—Docetaxel—pancreatic cancer	0.000657	0.00262	CcSEcCtD
Dronedarone—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000656	0.00261	CcSEcCtD
Dronedarone—Asthenia—Sunitinib—pancreatic cancer	0.000651	0.0026	CcSEcCtD
Dronedarone—Hypokalaemia—Epirubicin—pancreatic cancer	0.000646	0.00257	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000646	0.00257	CcSEcCtD
Dronedarone—Fatigue—Irinotecan—pancreatic cancer	0.000645	0.00257	CcSEcCtD
Dronedarone—Pruritus—Sunitinib—pancreatic cancer	0.000642	0.00256	CcSEcCtD
Dronedarone—Erythema—Docetaxel—pancreatic cancer	0.000633	0.00252	CcSEcCtD
Dronedarone—Dyspepsia—Fluorouracil—pancreatic cancer	0.00063	0.00251	CcSEcCtD
Dronedarone—Nausea—Tamoxifen—pancreatic cancer	0.00063	0.00251	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000629	0.00251	CcSEcCtD
Dronedarone—Fatigue—Gemcitabine—pancreatic cancer	0.000628	0.0025	CcSEcCtD
Dronedarone—Nausea—Erlotinib—pancreatic cancer	0.000623	0.00248	CcSEcCtD
Dronedarone—Diarrhoea—Sunitinib—pancreatic cancer	0.000621	0.00247	CcSEcCtD
Dronedarone—Dysgeusia—Docetaxel—pancreatic cancer	0.00062	0.00247	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000618	0.00246	CcSEcCtD
Dronedarone—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000615	0.00245	CcSEcCtD
Dronedarone—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000612	0.00244	CcSEcCtD
Dronedarone—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000597	0.00238	CcSEcCtD
Dronedarone—Abdominal pain—Irinotecan—pancreatic cancer	0.000591	0.00236	CcSEcCtD
Dronedarone—Vomiting—Sunitinib—pancreatic cancer	0.000577	0.0023	CcSEcCtD
Dronedarone—Rash—Sunitinib—pancreatic cancer	0.000572	0.00228	CcSEcCtD
Dronedarone—Dermatitis—Sunitinib—pancreatic cancer	0.000572	0.00228	CcSEcCtD
Dronedarone—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.00056	0.00223	CcSEcCtD
Dronedarone—Pneumonia—Epirubicin—pancreatic cancer	0.00055	0.00219	CcSEcCtD
Dronedarone—Nausea—Sunitinib—pancreatic cancer	0.000539	0.00215	CcSEcCtD
Dronedarone—Asthenia—Irinotecan—pancreatic cancer	0.000537	0.00214	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000536	0.00213	CcSEcCtD
Dronedarone—Asthenia—Gemcitabine—pancreatic cancer	0.000523	0.00208	CcSEcCtD
Dronedarone—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000518	0.00206	CcSEcCtD
Dronedarone—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000517	0.00206	CcSEcCtD
Dronedarone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000517	0.00206	CcSEcCtD
Dronedarone—Pruritus—Gemcitabine—pancreatic cancer	0.000515	0.00205	CcSEcCtD
Dronedarone—Diarrhoea—Irinotecan—pancreatic cancer	0.000512	0.00204	CcSEcCtD
Dronedarone—Pneumonia—Doxorubicin—pancreatic cancer	0.000509	0.00203	CcSEcCtD
Dronedarone—Nervous system disorder—Docetaxel—pancreatic cancer	0.000507	0.00202	CcSEcCtD
Dronedarone—Pruritus—Fluorouracil—pancreatic cancer	0.000507	0.00202	CcSEcCtD
Dronedarone—Skin disorder—Docetaxel—pancreatic cancer	0.000502	0.002	CcSEcCtD
Dronedarone—Bradycardia—Epirubicin—pancreatic cancer	0.0005	0.00199	CcSEcCtD
Dronedarone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000498	0.00199	CcSEcCtD
Dronedarone—Diarrhoea—Fluorouracil—pancreatic cancer	0.00049	0.00195	CcSEcCtD
Dronedarone—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000478	0.00191	CcSEcCtD
Dronedarone—Vomiting—Irinotecan—pancreatic cancer	0.000475	0.00189	CcSEcCtD
Dronedarone—Rash—Irinotecan—pancreatic cancer	0.000472	0.00188	CcSEcCtD
Dronedarone—Dermatitis—Irinotecan—pancreatic cancer	0.000471	0.00188	CcSEcCtD
Dronedarone—Vomiting—Gemcitabine—pancreatic cancer	0.000463	0.00185	CcSEcCtD
Dronedarone—Bradycardia—Doxorubicin—pancreatic cancer	0.000462	0.00184	CcSEcCtD
Dronedarone—Rash—Gemcitabine—pancreatic cancer	0.000459	0.00183	CcSEcCtD
Dronedarone—Dermatitis—Gemcitabine—pancreatic cancer	0.000459	0.00183	CcSEcCtD
Dronedarone—Cardiac disorder—Epirubicin—pancreatic cancer	0.000456	0.00181	CcSEcCtD
Dronedarone—Vomiting—Fluorouracil—pancreatic cancer	0.000455	0.00181	CcSEcCtD
Dronedarone—Dyspepsia—Docetaxel—pancreatic cancer	0.000455	0.00181	CcSEcCtD
Dronedarone—Rash—Fluorouracil—pancreatic cancer	0.000452	0.0018	CcSEcCtD
Dronedarone—Dermatitis—Fluorouracil—pancreatic cancer	0.000451	0.0018	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000446	0.00178	CcSEcCtD
Dronedarone—Fatigue—Docetaxel—pancreatic cancer	0.000446	0.00178	CcSEcCtD
Dronedarone—Angiopathy—Epirubicin—pancreatic cancer	0.000445	0.00177	CcSEcCtD
Dronedarone—Nausea—Irinotecan—pancreatic cancer	0.000444	0.00177	CcSEcCtD
Dronedarone—Immune system disorder—Epirubicin—pancreatic cancer	0.000443	0.00177	CcSEcCtD
Dronedarone—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000442	0.00176	CcSEcCtD
Dronedarone—Nausea—Gemcitabine—pancreatic cancer	0.000433	0.00172	CcSEcCtD
Dronedarone—Erythema—Epirubicin—pancreatic cancer	0.000427	0.0017	CcSEcCtD
Dronedarone—Nausea—Fluorouracil—pancreatic cancer	0.000425	0.00169	CcSEcCtD
Dronedarone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000423	0.00168	CcSEcCtD
Dronedarone—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000421	0.00168	CcSEcCtD
Dronedarone—Dysgeusia—Epirubicin—pancreatic cancer	0.000418	0.00167	CcSEcCtD
Dronedarone—Angiopathy—Doxorubicin—pancreatic cancer	0.000412	0.00164	CcSEcCtD
Dronedarone—Immune system disorder—Doxorubicin—pancreatic cancer	0.00041	0.00163	CcSEcCtD
Dronedarone—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000409	0.00163	CcSEcCtD
Dronedarone—Abdominal pain—Docetaxel—pancreatic cancer	0.000409	0.00163	CcSEcCtD
Dronedarone—Erythema—Doxorubicin—pancreatic cancer	0.000395	0.00157	CcSEcCtD
Dronedarone—Dysgeusia—Doxorubicin—pancreatic cancer	0.000387	0.00154	CcSEcCtD
Dronedarone—Asthenia—Docetaxel—pancreatic cancer	0.000371	0.00148	CcSEcCtD
Dronedarone—Pruritus—Docetaxel—pancreatic cancer	0.000366	0.00146	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000361	0.00144	CcSEcCtD
Dronedarone—Diarrhoea—Docetaxel—pancreatic cancer	0.000354	0.00141	CcSEcCtD
Dronedarone—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000349	0.00139	CcSEcCtD
Dronedarone—Nervous system disorder—Epirubicin—pancreatic cancer	0.000342	0.00136	CcSEcCtD
Dronedarone—Skin disorder—Epirubicin—pancreatic cancer	0.000339	0.00135	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000334	0.00133	CcSEcCtD
Dronedarone—Vomiting—Docetaxel—pancreatic cancer	0.000329	0.00131	CcSEcCtD
Dronedarone—Rash—Docetaxel—pancreatic cancer	0.000326	0.0013	CcSEcCtD
Dronedarone—Dermatitis—Docetaxel—pancreatic cancer	0.000326	0.0013	CcSEcCtD
Dronedarone—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000323	0.00129	CcSEcCtD
Dronedarone—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000316	0.00126	CcSEcCtD
Dronedarone—Skin disorder—Doxorubicin—pancreatic cancer	0.000313	0.00125	CcSEcCtD
Dronedarone—Nausea—Docetaxel—pancreatic cancer	0.000307	0.00122	CcSEcCtD
Dronedarone—Dyspepsia—Epirubicin—pancreatic cancer	0.000307	0.00122	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000301	0.0012	CcSEcCtD
Dronedarone—Fatigue—Epirubicin—pancreatic cancer	0.000301	0.0012	CcSEcCtD
Dronedarone—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000285	0.00114	CcSEcCtD
Dronedarone—Dyspepsia—Doxorubicin—pancreatic cancer	0.000284	0.00113	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000279	0.00111	CcSEcCtD
Dronedarone—Fatigue—Doxorubicin—pancreatic cancer	0.000278	0.00111	CcSEcCtD
Dronedarone—Abdominal pain—Epirubicin—pancreatic cancer	0.000276	0.0011	CcSEcCtD
Dronedarone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000264	0.00105	CcSEcCtD
Dronedarone—Abdominal pain—Doxorubicin—pancreatic cancer	0.000255	0.00102	CcSEcCtD
Dronedarone—Asthenia—Epirubicin—pancreatic cancer	0.00025	0.000997	CcSEcCtD
Dronedarone—Pruritus—Epirubicin—pancreatic cancer	0.000247	0.000983	CcSEcCtD
Dronedarone—Diarrhoea—Epirubicin—pancreatic cancer	0.000239	0.00095	CcSEcCtD
Dronedarone—Asthenia—Doxorubicin—pancreatic cancer	0.000231	0.000922	CcSEcCtD
Dronedarone—Pruritus—Doxorubicin—pancreatic cancer	0.000228	0.000909	CcSEcCtD
Dronedarone—Vomiting—Epirubicin—pancreatic cancer	0.000222	0.000883	CcSEcCtD
Dronedarone—Diarrhoea—Doxorubicin—pancreatic cancer	0.000221	0.000879	CcSEcCtD
Dronedarone—Rash—Epirubicin—pancreatic cancer	0.00022	0.000876	CcSEcCtD
Dronedarone—Dermatitis—Epirubicin—pancreatic cancer	0.00022	0.000875	CcSEcCtD
Dronedarone—Nausea—Epirubicin—pancreatic cancer	0.000207	0.000825	CcSEcCtD
Dronedarone—Vomiting—Doxorubicin—pancreatic cancer	0.000205	0.000817	CcSEcCtD
Dronedarone—Rash—Doxorubicin—pancreatic cancer	0.000203	0.00081	CcSEcCtD
Dronedarone—Dermatitis—Doxorubicin—pancreatic cancer	0.000203	0.00081	CcSEcCtD
Dronedarone—Nausea—Doxorubicin—pancreatic cancer	0.000192	0.000763	CcSEcCtD
Dronedarone—ADRA2A—Signaling Pathways—TSC2—pancreatic cancer	1.17e-05	6.01e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PIK3CB—pancreatic cancer	1.17e-05	5.99e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—TYMS—pancreatic cancer	1.17e-05	5.98e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—AKT1—pancreatic cancer	1.16e-05	5.98e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—EGFR—pancreatic cancer	1.16e-05	5.96e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PIK3CB—pancreatic cancer	1.16e-05	5.94e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PTGS2—pancreatic cancer	1.16e-05	5.94e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	1.15e-05	5.9e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—APOE—pancreatic cancer	1.15e-05	5.88e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—EGFR—pancreatic cancer	1.14e-05	5.86e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	1.14e-05	5.84e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—PIK3CA—pancreatic cancer	1.12e-05	5.77e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—KDR—pancreatic cancer	1.12e-05	5.76e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PIK3CD—pancreatic cancer	1.12e-05	5.75e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	1.11e-05	5.72e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	1.11e-05	5.72e-05	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—AKT1—pancreatic cancer	1.11e-05	5.71e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CXCL8—pancreatic cancer	1.11e-05	5.71e-05	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.11e-05	5.69e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—HRAS—pancreatic cancer	1.1e-05	5.67e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PIK3CD—pancreatic cancer	1.1e-05	5.66e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	1.1e-05	5.65e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.1e-05	5.64e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—KRAS—pancreatic cancer	1.1e-05	5.63e-05	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.09e-05	5.6e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—TP53—pancreatic cancer	1.09e-05	5.59e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.09e-05	5.59e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PIK3CD—pancreatic cancer	1.09e-05	5.58e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—APOE—pancreatic cancer	1.08e-05	5.55e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—KRAS—pancreatic cancer	1.08e-05	5.54e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.08e-05	5.53e-05	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—AKT1—pancreatic cancer	1.07e-05	5.51e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	1.07e-05	5.48e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CASP3—pancreatic cancer	1.06e-05	5.46e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	1.06e-05	5.43e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	1.05e-05	5.41e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PIK3CB—pancreatic cancer	1.04e-05	5.36e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—HRAS—pancreatic cancer	1.04e-05	5.34e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CCND1—pancreatic cancer	1.04e-05	5.32e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	1.03e-05	5.31e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	1.03e-05	5.31e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CTNNB1—pancreatic cancer	1.03e-05	5.27e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.02e-05	5.26e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	1.02e-05	5.25e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	1.01e-05	5.21e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	1.01e-05	5.2e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PTEN—pancreatic cancer	1.01e-05	5.18e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—PIK3CA—pancreatic cancer	1.01e-05	5.17e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	1.01e-05	5.17e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MMP9—pancreatic cancer	1.01e-05	5.16e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CXCL8—pancreatic cancer	1e-05	5.15e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PTEN—pancreatic cancer	1e-05	5.13e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—HRAS—pancreatic cancer	9.98e-06	5.12e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—PIK3CA—pancreatic cancer	9.91e-06	5.09e-05	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	9.79e-06	5.02e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	9.79e-06	5.02e-05	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—AKT1—pancreatic cancer	9.77e-06	5.02e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CG—pancreatic cancer	9.76e-06	5.01e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PIK3CB—pancreatic cancer	9.76e-06	5.01e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—AKT1—pancreatic cancer	9.76e-06	5.01e-05	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—AKT1—pancreatic cancer	9.7e-06	4.98e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	9.7e-06	4.98e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.7e-06	4.98e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CASP3—pancreatic cancer	9.61e-06	4.93e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PIK3CB—pancreatic cancer	9.61e-06	4.93e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	9.58e-06	4.92e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	9.48e-06	4.87e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—APOE—pancreatic cancer	9.48e-06	4.87e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	9.44e-06	4.85e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	9.43e-06	4.84e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PPARG—pancreatic cancer	9.42e-06	4.84e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTGS2—pancreatic cancer	9.39e-06	4.82e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CXCL8—pancreatic cancer	9.38e-06	4.81e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCND1—pancreatic cancer	9.35e-06	4.8e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	9.35e-06	4.8e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—HRAS—pancreatic cancer	9.32e-06	4.78e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—SRC—pancreatic cancer	9.27e-06	4.76e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CTNNB1—pancreatic cancer	9.26e-06	4.75e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CD44—pancreatic cancer	9.26e-06	4.75e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CXCL8—pancreatic cancer	9.23e-06	4.74e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—AKT1—pancreatic cancer	9.19e-06	4.72e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—HRAS—pancreatic cancer	9.17e-06	4.71e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	9.17e-06	4.7e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	9.11e-06	4.68e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	9.09e-06	4.67e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MMP9—pancreatic cancer	9.08e-06	4.66e-05	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—AKT1—pancreatic cancer	9.06e-06	4.65e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—VEGFA—pancreatic cancer	9.03e-06	4.64e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PTEN—pancreatic cancer	9.03e-06	4.63e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.01e-06	4.62e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CASP3—pancreatic cancer	8.98e-06	4.61e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—STAT3—pancreatic cancer	8.94e-06	4.59e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—APOE—pancreatic cancer	8.93e-06	4.59e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—NRAS—pancreatic cancer	8.92e-06	4.58e-05	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—AKT1—pancreatic cancer	8.92e-06	4.58e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	8.9e-06	4.57e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	8.89e-06	4.56e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GCG—pancreatic cancer	8.88e-06	4.56e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CASP3—pancreatic cancer	8.83e-06	4.53e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—AKT1—pancreatic cancer	8.81e-06	4.52e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	8.8e-06	4.52e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCND1—pancreatic cancer	8.74e-06	4.48e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CTNNB1—pancreatic cancer	8.65e-06	4.44e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCND1—pancreatic cancer	8.6e-06	4.41e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CD—pancreatic cancer	8.58e-06	4.41e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CG—pancreatic cancer	8.56e-06	4.39e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	8.53e-06	4.38e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	8.52e-06	4.37e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MMP9—pancreatic cancer	8.48e-06	4.35e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—SRC—pancreatic cancer	8.45e-06	4.34e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PTEN—pancreatic cancer	8.43e-06	4.33e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	8.37e-06	4.3e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	8.35e-06	4.29e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—STK11—pancreatic cancer	8.35e-06	4.29e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MYC—pancreatic cancer	8.31e-06	4.27e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	8.3e-06	4.26e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TGFB1—pancreatic cancer	8.29e-06	4.26e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PPARG—pancreatic cancer	8.26e-06	4.24e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	8.23e-06	4.22e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—AKT1—pancreatic cancer	8.23e-06	4.22e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	8.2e-06	4.21e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTEN—pancreatic cancer	8.19e-06	4.21e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	8.18e-06	4.2e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	8.15e-06	4.19e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	8.15e-06	4.18e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	8.15e-06	4.18e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	8.13e-06	4.17e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EGFR—pancreatic cancer	8.13e-06	4.17e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	8.1e-06	4.16e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	8.07e-06	4.14e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	8.06e-06	4.14e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	8.05e-06	4.13e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	7.93e-06	4.07e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	7.92e-06	4.07e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	7.85e-06	4.03e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—SRC—pancreatic cancer	7.82e-06	4.01e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PPARG—pancreatic cancer	7.78e-06	3.99e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	7.7e-06	3.95e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	7.68e-06	3.94e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	7.64e-06	3.92e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	7.62e-06	3.91e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	7.62e-06	3.91e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MYC—pancreatic cancer	7.57e-06	3.89e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	7.57e-06	3.88e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	7.56e-06	3.88e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	7.55e-06	3.88e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	7.54e-06	3.87e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	7.52e-06	3.86e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CD—pancreatic cancer	7.52e-06	3.86e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	7.5e-06	3.85e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	7.5e-06	3.85e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	7.48e-06	3.84e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CB—pancreatic cancer	7.48e-06	3.84e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	7.42e-06	3.81e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	7.42e-06	3.81e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTGS2—pancreatic cancer	7.41e-06	3.81e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	7.41e-06	3.8e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	7.41e-06	3.8e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	7.37e-06	3.78e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	7.36e-06	3.78e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	7.34e-06	3.77e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	7.29e-06	3.74e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	7.19e-06	3.69e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—TYMS—pancreatic cancer	7.18e-06	3.69e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	7.12e-06	3.65e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	7.1e-06	3.64e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	7.09e-06	3.64e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	7.05e-06	3.62e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	7.03e-06	3.61e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	7.01e-06	3.6e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	7e-06	3.59e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	6.99e-06	3.59e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	6.93e-06	3.56e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	6.9e-06	3.54e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	6.89e-06	3.54e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	6.88e-06	3.53e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	6.86e-06	3.52e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	6.85e-06	3.52e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	6.84e-06	3.51e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	6.82e-06	3.5e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	6.75e-06	3.46e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	6.68e-06	3.43e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	6.66e-06	3.42e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	6.59e-06	3.38e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	6.58e-06	3.38e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CB—pancreatic cancer	6.56e-06	3.36e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	6.53e-06	3.35e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTGS2—pancreatic cancer	6.5e-06	3.33e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	6.48e-06	3.32e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTEN—pancreatic cancer	6.47e-06	3.32e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	6.43e-06	3.3e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	6.37e-06	3.27e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	6.37e-06	3.27e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	6.35e-06	3.26e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TP53—pancreatic cancer	6.22e-06	3.19e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	6.19e-06	3.18e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	6.18e-06	3.17e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	6.16e-06	3.16e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	6.13e-06	3.14e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	6.13e-06	3.14e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTGS2—pancreatic cancer	6.12e-06	3.14e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	6.11e-06	3.14e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	6.11e-06	3.14e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	5.99e-06	3.08e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	5.95e-06	3.05e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	5.95e-06	3.05e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	5.89e-06	3.02e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	5.86e-06	3.01e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—APOE—pancreatic cancer	5.84e-06	3e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—AKT1—pancreatic cancer	5.81e-06	2.98e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	5.78e-06	2.97e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	5.76e-06	2.96e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	5.76e-06	2.95e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	5.69e-06	2.92e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	5.68e-06	2.91e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTEN—pancreatic cancer	5.66e-06	2.91e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	5.66e-06	2.91e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	5.66e-06	2.91e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	5.57e-06	2.86e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	5.5e-06	2.83e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	5.42e-06	2.78e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTEN—pancreatic cancer	5.34e-06	2.74e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.27e-06	2.71e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	5.26e-06	2.7e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	5.25e-06	2.7e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	5.2e-06	2.67e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	5.2e-06	2.67e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PPARG—pancreatic cancer	5.09e-06	2.61e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	5.03e-06	2.58e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	4.86e-06	2.49e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	4.83e-06	2.48e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	4.81e-06	2.47e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	4.78e-06	2.46e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—AKT1—pancreatic cancer	4.72e-06	2.42e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	4.67e-06	2.4e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.63e-06	2.38e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CA—pancreatic cancer	4.56e-06	2.34e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	4.47e-06	2.29e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	4.25e-06	2.18e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	4.04e-06	2.07e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4e-06	2.05e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CA—pancreatic cancer	4e-06	2.05e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	3.95e-06	2.03e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	3.77e-06	1.93e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—AKT1—pancreatic cancer	3.73e-06	1.91e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.49e-06	1.79e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—AKT1—pancreatic cancer	3.26e-06	1.68e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—AKT1—pancreatic cancer	3.08e-06	1.58e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.46e-06	1.26e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.01e-06	1.03e-05	CbGpPWpGaD
